TGF-β suppresses the early stages of tumour development by inducing cell-cycle arrest and apoptosis, but it later promotes tumour progression by increasing proliferative and anti-apoptotic signals via transactivating PI3K/AKT, MAPK/ERK, or other mitogenic pathways [60,85,86]. Here, AKT1 is linked to neoplasm.